Genmab A/S (GMAB)

NMS – Real vaqt narxi. Valyuta: USD

31.40

+0.55 (1.77%)

Bozor ochiq: Aug 12, 2026, 3:58 PM EDT

31.24

+0.39 (1.28%)

Oldingi bozordan keyin: Aug 11, 2026, 7:34 PM EDT

11.08.2026

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; August 11, 2026 – Genmab A/S (Nasdaq: GMAB) will increase its share capital by 24,592 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the existing shareholders of the Company or others.

07.08.2026

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

06.08.2026

Genmab A/S Q2 Earnings Call Highlights

Genmab A/S NASDAQ: GMAB reported first-half 2026 revenue growth of 25% year over year and raised its full-year financial outlook, citing continued momentum from DARZALEX, EPKINLY and the broader portfolio. The company also outlined upcoming late-stage trial readouts and announced two new Phase III studies of petosemtamab in colorectal cancer.

Videolar

No Data

There is no data to display

Press-relizlar

11.08.2026

Genmab A/S (GMAB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Genmab A/S (GMAB)

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Videolar

No Data

Press-relizlar

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Videolar

No Data

Press-relizlar

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Search stocks

Genmab A/S (GMAB)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Genmab A/S (GMAB)

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Videolar

No Data

Press-relizlar

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Genmab A/S (GMAB) Q2 2026 Earnings Call Transcript

Genmab A/S Q2 Earnings Call Highlights

Videolar

No Data

Press-relizlar

Capital Increase in Genmab as a Result of Employee Warrant Exercise